- Research article
- Open Access
- Open Peer Review
Trajectories of growth and symptoms of attention-deficit/hyperactivity disorder in children: a longitudinal study
BMC Pediatricsvolume 11, Article number: 84 (2011)
Empirical evidence suggests that prenatal growth is associated with attention deficit/hyperactivity disorder (ADHD) and its symptoms. Data on the importance of postnatal growth is, however scanty. We studied whether pre- and postnatal growth up to 56 months is associated with symptoms of ADHD in children.
A longitudinal regional birth cohort study comprising 893 children followed up to 56 months. The associations between pre- and postnatal growth and parent-rated ADHD symptoms of the child were analyzed with multiple linear regression analyses and repeated-measures analyzes of covariance.
Children born lighter, thinner, shorter, and with a smaller head circumference, adjusted for length of gestation, received higher parent-rated ADHD symptoms scores at 56 months. Further, smaller head circumference throughout the period of growth from birth up to 56 months was related to higher ADHD symptoms scores. The associations changed only little after adjusting for several pre- and neonatal factors. The associations were not modified by sex and there were no evidence of non-linear associations.
Slower prenatal growth in weight, body-mass index, length, and head circumference may pose a risk for higher ADHD symptoms in childhood. The consistently smaller head circumference from birth up to 56 months characterizing children with higher ADHD symptoms may point to a lack of catch-up growth in head circumference in childhood as a predisposing factor.
Attention deficit/hyperactivity disorder (ADHD) is among the most common neuropsychiatric disorders in childhood with a worldwide prevalence rate of approximately 5% . Behavioral symptoms characterizing ADHD are even more common, and include inattention, hyperactivity, and impulsiveness . The etiology of ADHD is multifaceted. Together with genetic and environmental factors both pre- and postnatal growth may influence its development [3, 4]. Indeed, mounting empirical evidence shows that prematurity and small body size at birth are associated with ADHD and its symptoms [5–11]. The evidence for the importance of postnatal growth is, however scanty and often confounded by stimulant medication used in treating ADHD symptomatology; stimulant-medication may per se compromise physical growth. Thus, it remains unknown if postnatal growth is etiologically associated with ADHD or is a consequence of the stimulant-medication 
In stimulant-naïve child and adolescent samples, those who gain higher scores in ADHD symptoms or who fulfill the criteria of the disorder have in cross-sectional studies been shown both to be shorter [13, 14] or taller [15, 16], to have higher weight  and both to have a lower  or a higher [16, 18, 19] body-mass index (BMI). Yet, to our knowledge only two studies to date have addressed the role of physical growth in ADHD: the first compared growth of 48 boys with ADHD in relation to population norms and found a distinct suppression of growth in height from 9 to 14 years, earlier onset of adolescent growth spurt and a higher velocity of growth in that moment . The second study showed in 87 extremely-low-birth-weight boys and girls that growth in head circumference between birth and two years did not predict parent/teacher-rated ADHD at school-age . The current study will test if growth in height, weight, BMI and head circumference from birth up to five, 20, and 56 months of age is associated with parent-rated ADHD symptoms at 56 months. Thus, the current study will add new information of the association between the postnatal growth from birth to preschool-age and symptoms of ADHD in a stimulant-naïve sample of girls and boys. By using different time points and a range of anthropometric measurements the study will also show whether there are particular periods of growth or measures that are specifically related to symptoms of ADHD.
The study cohort comprised infants participating in the Arvo Ylppö Longitudinal Study (AYLS) [21, 22]. Of a total of 15,311 deliveries in the seven maternity hospitals in the county of Uusimaa, Finland, we identified all live-born infants between March 15, 1985 and March 14, 1986 who were admitted to the neonatal wards of the obstetric units or transferred to the Neonatal Intensive Care Unit of the Hospital for Children and Adolescents, University of Helsinki, within 10 days of birth. The population ranged from severely ill preterm infants to infants born at term requiring only brief inpatient observation. In total, there were 1,535 admitted infants (n = 867 boys). In addition, 658 infants (n = 328 boys), born during the same period but not admitted to the neonatal ward, were randomly recruited from the three largest maternity hospitals in the study area. Participants were invited to clinical follow-ups at 5 and 20 months of corrected age and at 56 months of age. The study protocol was approved by the Ethical Committees of Helsinki City Maternity Hospital, Helsinki University Central Hospital, and Jorvi Hospital, and the parent(s) gave their informed consent.
Of the 2,193 infants 2,125 survived to 56 months of age. We excluded 80 infants with congenital malformations and chromosomal abnormalities, and Mendelian disorders potentially affecting growth. At least one birth size measure, control variable and/or parental ratings of ADHD at 56 months was lacking for 1,232 children. Thus, the participants in the present study included 893 children: boys (n = 490) and girls (n = 403). The original cohort is described in detail elsewhere [22, 23].
The study participants (n = 893) did not differ from those who were lost to follow-up due to lack of information on any birth size measure, gestational age and/or pre- and neonatal control variables (n = 225) in sex, multiple pregnancy, mother's height, on BMI at five months, or in any body size measures at 20 and 56 months (all p-values > .05). However, those lost to follow-up were more likely to have been admitted to a neonatal ward, to come from less educated families, to have younger mothers, and mothers who smoked more during pregnancy. Furthermore, they were lighter, shorter and had smaller head circumference at birth, and at 5 months, and were also thinner at birth, born earlier and less likely to be breast fed (all p-values < .04). Further, the study participants (n = 893) did not differ from those who were lost to follow-up due to lack of information on parental rated ADHD symptoms (n = 927) in any body size or control variables, except that those who did not had ADHD symptoms scores available were shorter at 5 and 20 months and their mothers had smoked more during pregnancy (p-values < .049). As the ADHD symptoms were measured at the age of 56 months the participants were not yet treated with stimulant medication, even if symptoms of ADHD might already be present.
Body size at birth, and in infancy and childhood
Data on the newborns' date of birth, weight (g), length (cm) and head circumference (cm) were extracted from hospital birth records, and BMI was calculated (kg/m2). The same anthropometric measures were taken during the clinical visits at five and 20 months of corrected age and at 56 months.
The growth variables were the standardized residuals from the linear regression models where body size at each time point was regressed on corresponding size measures at all earlier time points, thus creating completely uncorrelated residuals reflecting growth conditional on previous history. The residuals provided information on whether growth by a particular age was faster or slower than would have been predicted from previous measurements.
Gestational age was determined from the date of the mother's last menstrual period and/or ultrasound examination. All the infants were given an assessment of clinical maturity . When there was a difference in the estimates of more than two weeks, gestational age was corrected according to Dubowitz maturity scale, except for preterms under 32 weeks of gestational age.
Parental Ratings of ADHD symptoms
At the 56-month follow-up the parents evaluated the child's ADHD symptoms with the Conners' Hyperactivity Index -parent version . This index is composed of ten items rated on a four-point scale (0 = not at all to 3 = very much). Sample items are: "Inattentive, easily distracted" and "Restless or overactive". The items were summed with higher scores reflecting higher levels of ADHD symptoms. Cronbach's alpha was .85.
We tested if the associations between body size/growth variables and ADHD symptoms were confounded by the child's sex, gestational age, admission to neonatal ward during the first ten days, multiple pregnancy (singleton vs. multiple), mother's smoking during pregnancy (none, 1-10, > 10 cigarettes/day), parental education (four point scale of highest self-reported level of education of either parent: from high = university education to low = elementary school education or less), maternal age (years), maternal height (cm).
Body size at birth and at five, 20, and 56 months of age was converted into z scores (Mean = 0; Standard Deviation (SD) = 1) by sex, and birth size measures additionally by gestational age. The standardized scores represent the difference from mean value for the sample of control children participating in the current study (i.e. those who were not admitted to neonatal ward).
As the primary data analytical tool, we used multiple linear regression analysis. We examined, first, if body size at birth, and at five, 20 and 56 months, and, second, if growth from birth to five, 20 and 56 months of age, conditional on previous history, predicted the child's ADHD symptoms at 56 months as a continuous score. As the associations are not necessarily linear, we also tested the potential non-linearity of the associations by entering squared terms of body size at each time point into the regression equation following the linear terms.
Finally, we examined trajectories of growth by using repeated-measures analysis of covariance (ANCOVA). In the ANCOVA body size at birth, five, 20 and 56 months of age represented the within-person dependent variables, and quintiles of ADHD symptoms at 56 months represented the independent between-person grouping variable. All associations were tested after controlling for the sex of the child, and then further controlling for pre- and neonatal covariates.
We also re-ran analyzes in a subgroup of children not admitted to neonatal ward during first 10 days, and who had birth weight ≥ 2,500 g and were born at term (≥ 37 weeks of gestation). This remaining subgroup included 293 children.
Table 1 shows characteristics of the sample divided by sex. Compared with girls, boys had higher scores on ADHD-symptoms at 56 months. Boys were bigger at all measurement points and were more likely to have been admitted to a neonatal ward. In addition, we tested interactional effects of sex by adding an interaction term 'sex × body size (each anthropometric variable at each time point in separate models)' into the regression equation in addition to the main effects of these two centered variables in predicting ADHD-symptoms. These analyses revealed no significant interactions (all p-values > .13). All the main results are presented in the pooled sample. When testing for associations between covariate variables and ADHD-symptoms, we found that after controlling for the child's sex, children of younger mothers, and of parents with a lower educational level had higher ADHD-symptoms scores (p-values < .002; all other p-values > .13).
Relative body size and parent-rated ADHD symptoms at 56 months
Table 2 shows that lower weight, shorter length, smaller head circumference and lower BMI at birth were significantly associated with higher ADHD symptoms scores after controlling for child's sex. Table 2 also shows that smaller head circumference at five, 20 and 56 months of age were significantly associated with higher ADHD symptoms scores. After controlling for pre- and neonatal covariates, the association between head circumference at 20 months and ADHD symptoms were rendered to marginal significance (from p = .02 to p = .08), whereas the previously marginally significant association between lower BMI at 56 months and higher ADHD symptoms became significant (from p = .09 to p = .04).
Growth and parent-rated ADHD symptoms at 56 months
Growth conditional on history
After controlling for child's sex there were no significant associations between growth (conditional on history) and ADHD symptoms. However, after controlling for the rest of the covariates the previously marginally significant association (p = 0.06) between a slower gain in BMI from 20 to 56 months and higher ADHD symptoms scores became significant (B = -0.37, 95% Confidence Interval (CI): -0.70 to -0.32, p = .03) (Table 3.).
Figure 1 displays the growth trajectory of head circumference in quintiles of ADHD symptoms scores in a fully controlled model. The pattern of the growth trajectory across time was not significantly different between the ADHD symptoms group (ADHD grouping × time, p = .93). However, children who had ADHD symptoms scores in the highest quintile displayed the lowest head circumference and children having the lowest ADHD symptoms scores displayed the highest head circumference from birth to 56 months (Mean difference in SD units = 0.27, 95% CI = 0.06 to 0.49, p = .01). Head circumferences of the children with ADHD symptoms scores in the middle three quintiles fell between these two extreme quintiles. The analyses of other growth measures by quintiles of ADHD symptoms were not statistically significant.
Associations in a subgroup of full term and normal birth weight children not admitted to neonatal ward
Finally, we tested whether the observed results remained similar in a subgroup of children who were not admitted to the neonatal ward, had birth weight ≥ 2,500 g and were born at term (≥ 37 weeks of gestation) (n = 293). We found that in a fully controlled model lower weight (p = 0.005), smaller head circumference (p = 0.06) and lower BMI (p = 0.001) at birth were significantly or marginally significantly associated with higher ADHD symptoms scores. However, birth length was not associated with the ADHD symptoms (p = 0.27). Further, smaller head circumference at five (p = 0.05), 20 (p = 0.04) and 56 months of age (p = 0.03) were associated with higher ADHD symptoms scores. None of the previously found associations between relative BMI at 56 months and growth in BMI from 20 to 56 months and ADHD symptoms were present in this subgroup. Finally, the growth trajectory of head circumference in quintiles of ADHD symptoms scores was similar to that found in a total sample. Children who had ADHD symptoms scores in the highest quintile displayed the lowest head circumference and children having the lowest ADHD symptoms scores displayed the highest head circumference from birth to 56 months (Mean difference in SD units = 0.37, 95% CI = 0.02 to 0.72, p = .04).
We found in a sample of 893 Finnish children that those born lighter in weight, thinner in BMI, shorter in stature and smaller in head circumference were rated by their parents as having higher ADHD symptoms scores at 56 months. Further, we found that a smaller head circumference throughout the period of growth from birth to 56 months was related to higher ADHD symptoms. We also found that a slower gain in BMI from 20 to 56 months and a lower relative BMI at 56 months was associated with higher ADHD symptoms. Controlling for several pre- and neonatal covariates had little effect on the results. The associations were not modified by sex and there were no non-linear associations.
We also found a similar pattern of findings in a subgroup of term (≥ 37 weeks of gestation), normal birth weight (≥ 2,500 g) children not admitted to neonatal ward (n = 293) with three clear exceptions: the association between birth length, growth in BMI from 20 to 56 months and the relative BMI at 56 months and ADHD symptoms scores were turned to non-significant.
There are several strengths in this study. We were able to examine the early childhood growth using multiple anthropometric variables in a prospective study design. Most of the existing studies have been conducted with data derived from clinical practice, which may favor a higher than expected rate of positive findings . Also studies with stimulant-naïve sample are needed to evaluate whether potential growth deficits may indeed be etiologically related to ADHD and not a consequence of stimulant-medication used to treat symptomatology . Further, we had the whole birth weight range available and could control for several variables that may have an impact on growth and/or ADHD symptoms. Controlling for covariates increases the likelihood that the findings are true and not due any confounding factor related to the both independent and dependent variables. We could also exclude children with severe conditions that could have potentially confounded the findings.
There are also some limitations. For practical reasons, several parents did not receive or fill in the ADHD questionnaire. However, those who did and did not receive/fill in the questionnaire did not differ from each other in most of the measured variables. However, compared to those lost to follow-up the participants were taller at five and at 20 months, and their mothers smoked less during pregnancy. Therefore, the results may be more characteristic of children exposed to less adverse pre- and postnatal environments. Further, we had no information on the parental ADHD symptoms and were, thus, unable to take potential genetic susceptibility into account. Neither, did we have information on environmental postnatal factors as non-optimal parenting [27, 28] and family adversity  that have been shown to be related to symptoms of ADHD. However, we have controlled for parental education, which is a crude proxy of several environmental adversities. As we have used multiple measures of body size at four different time points, we have ended up making multiple tests. However, we decided not to use the correction for multiple testing (e.g., Bonferroni correction). First, as the number of Type I errors cannot decrease without increasing type II errors . Second, theoretical assumption behind the correction of multiple testing is that all null hypotheses are true simultaneously, which was not of interest of our study. It is suggested simply describing carefully the used analyses is usually the most rational way of dealing with multiple testing .
We have previously shown with the same data that small for gestational age (SGA) status, rather than prematurity per se, may increase risk for symptoms of ADHD in young children . While current findings showing associations between smaller body size in weight, length, head circumference and BMI at birth and higher ADHD symptoms scores are in accordance with our and majority of others previous findings [5–8, 10, 11], they also extend them in significant ways. Of the few previous studies focusing on children born across the whole gestational age/birth weight range [e.g., [9, 32]] to our knowledge none has focused on birth weight, length, head circumference and BMI in a same study. In our cohort, birth weight and head circumference seem to have the strongest associations with parent rated ADHD symptoms.
With regard to postnatal growth, to our knowledge there are only three prior studies focusing on postnatal head circumference and ADHD or its symptoms. Ptcak et al.  suggested that 4-16 years-old boys with diagnosed ADHD have a smaller head circumference than the normal non-clinical population, although the association was only marginally significant among those boys who did not receive medication (n = 52, p = .07). Hack et al.  found among 249 very-low-birth-weight children that those who had a subnormal head size (less than the mean -2 SD for age) at 8 months of corrected age had a higher incidence of hyperactivity at 8-9 years. This association became, however, non-significant after controlling pre- and neonatal covariates. Finally, Stathis et al.  failed to find any significant associations among 87 extremely-low-birth weight born children between subnormal head circumference (comparison to norm z-scores) or head growth velocity from birth to 2 years and parent/teacher rated ADHD diagnoses at school-age. Because of differences in age of the samples and periods of growth, direct comparison of our results showing an association between a smaller head circumference throughout the period of growth from birth to 56 months with higher levels of ADHD symptoms at 56 months, with earlier findings is not possible. The current study is the only one that presents results in a relatively large cohort of children born across the whole birth weight range.
The mechanisms explaining the association between postnatal head circumference and ADHD symptoms remain speculative. Head circumference has been shown to correlate highly with total brain volume (from 1.7 to six years r = .93) . Smaller total brain volume, in turn, has been shown to be related to ADHD in several studies . Further, our results showing that those having the highest levels of parent rated ADHD symptoms were those who had the smaller head circumferences already at birth and had a persistently smallest head circumference across the early childhood pointing, at least partly, to the compromised prenatal period the effects of which the postnatal growth has not been able to correct. The longitudinal growth curves of total brain volumes have been shown to be roughly parallel, although at different levels, between patients with ADHD and healthy controls  suggesting that developmental processes are essentially healthy in ADHD, and that ADHD symptoms appear to reflect fixed earlier neurobiological insults or abnormalities. Another study  provided evidence that the pattern of brain maturation in ADHD was delayed, rather than abnormal. As the brain volume usually reaches its maximum volume by early adolescence  the age range of the participants in the current study does not allow conclusions whether the association between smaller head circumference and higher levels of ADHD symptoms reflect slow maturation that will disappear later.
We also found that lower relative BMI at 56 months and slower gain in BMI from 20 to 56 months was related to higher ADHD symptoms. Earlier studies have shown that ADHD or its symptoms are associated with higher BMI [16, 18, 19] rather than with thinness , or have not found associations with BMI [14, 40, 41]. All previous studies have, however, studied older participants or used diagnoses of ADHD. It should also be noted that our results became non-significant after excluding the participants who were admitted to neonatal ward during first ten days, were born preterm or had a birth weight < 2,500 g suggesting the stronger relationship among those born with compromised prenatal period or early health problems. However, our findings of slower gain in BMI may also reflect the measurement period from 20 to 56 months. At that time children start to move more by themselves. They may burn a lot of energy while hyperactive, but the ADHD-related abnormal eating behaviors (e.g. binge eating) that are present in older individuals may only have a minor role on the choices and amount of food consumed see .
Earlier studies on height and ADHD have been mainly cross-sectional and inconsistent in their findings [13–16, 43]. The one existing longitudinal study focusing on growth in height among 48 ADHD diagnosed boys from two to 17 years of age found a distinct suppression of growth in height from nine to 14 years, earlier onset of adolescent growth spurt and a higher velocity of growth in that moment . That study however differed from the current study in measurement of ADHD and in age range. Our longitudinal findings that parental rated ADHD symptoms at 56-months are not related to relative height at successive time points or to growth trajectories during the first years extend the knowledge of prior studies to years before ADHD-diagnoses are usually made.
In summary, the results point to the importance of a slower prenatal growth. The consistently smaller head circumference from birth to 56 months characterizing children with higher ADHD symptoms scores may point to the importance of a lack of catch-up growth in head in childhood as another predisposing factor. However, it should be kept in mind that the associations we found were relatively modest in effect size. Measurements of body size are nevertheless crude measurements of environmental conditions early in life, and any association may give a hint of a biologically significant relationship. Further, studies are clearly needed to illuminate the association between growth and ADHD throughout the entire period of growth.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007, 164: 942-948. 10.1176/appi.ajp.164.6.942.
Diagnostic and Statistical Manual of Mental Disorders. 2000, Washington, DC: American Psychiatric Association, Text revision, 4
Deault LC: A systematic review of parenting in relation to the development of comorbidities and functional impairments in children with attention-deficit/hyperactivity disorder (ADHD). Child Psychiatry Hum Dev. 2010, 41: 168-192. 10.1007/s10578-009-0159-4.
Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD: Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 2007, 17: 39-59. 10.1007/s11065-007-9019-9.
Delobel-Ayoub M, Kaminski M, Marret S, Burguet A, Marchand L, N'Guyen S, Matis J, Thiriez G, Fresson J, Arnaud C, Poher M, Larroque B, EPIPAGE Study Group: Behavioral outcome at 3 years of age in very preterm infants: the EPIPAGE study. Pediatrics. 2006, 117: 1996-2005. 10.1542/peds.2005-2310.
Wolke D, Samara M, Bracewell M, Marlow N: Specific language difficulties and school achievement in children born at 25 weeks of gestation or less. Journal of Pediatrics. 2008, 152: 256-262. 10.1016/j.jpeds.2007.06.043.
Strang-Karlsson S, Raikkonen K, Pesonen AK, Kajantie E, Paavonen EJ, Lahti J, Hovi P, Heinonen K, Jarvenpaa AL, Eriksson JG, Andersson S: Very low birth weight and behavioral symptoms of attention deficit hyperactivity disorder in young adulthood: the Helsinki study of very-low-birth-weight adults. The American Journal of Psychiatry. 2008, 165: 1345-1353. 10.1176/appi.ajp.2008.08010085.
Lahti J, Räikkönen K, Kajantie E, Heinonen K, Pesonen AK, Järvenpää AL, Strandberg T: Small body size at birth and behavioural symptoms of ADHD in children aged five to six years. Journal of Child Psychology and Psychiatry. 2006, 47: 1167-1174. 10.1111/j.1469-7610.2006.01661.x.
Heinonen K, Räikkönen K, Pesonen AK, Andersson S, Kajantie E, Eriksson JG, Wolke D, Lano A: Behavioural symptoms of attention deficit/hyperactivity disorder in preterm and term children born small and appropriate for gestational age: a longitudinal study. BMC Pediatrics. 2010, 10: 91-10.1186/1471-2431-10-91.
Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ: Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002, 288: 728-737. 10.1001/jama.288.6.728.
Schlotz W, Jones A, Godfrey KM, Phillips DI: Effortful control mediates associations of fetal growth with hyperactivity and behavioural problems in 7- to 9-year-old children. J Child Psychol Psychiatry. 2008, 49: 1228-1236.
Faraone SV, Biederman J, Morley CP, Spencer TJ: Effect of stimulants on height and weight: a review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry. 2008, 47: 994-1009.
Spencer T, Biederman J, Wilens T: Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics. 1998, 102: 501-506.
Spencer TJ, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE: Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?. Journal of the American Academy of Child and Adolescent Psychiatry. 1996, 35: 1460-1469. 10.1097/00004583-199611000-00014.
Hanc T, Cieslik J: Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches. Pediatrics. 2008, 121: e967-974. 10.1542/peds.2007-1532.
Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, Abikoff H, Oatis M, McCracken J, McGough J, Riddle M, Ghuman J, Cunningham C, Wigal S: Stimulant-related reductions of growth rates in the PATS. Journal of the American Academy of Child and Adolescent Psychiatry. 2006, 45: 1304-1313. 10.1097/01.chi.0000235075.25038.5a.
McGee R, Birkbeck J, Silva PA: Physical development of hyperactive boys. Developmental Medicine & Child Neurology. 1985, 27: 364-368.
Holtkamp K, Konrad K, Muller B, Heussen N, Herpertz S, Herpertz-Dahlmann B, Hebebrand J: Overweight and obesity in children with Attention-Deficit/Hyperactivity Disorder. International Journal of Obesity and Related Metabolic Disorders. 2004, 28: 685-689. 10.1038/sj.ijo.0802623.
Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B: Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD?. Journal of the American Academy of Child and Adolescent Psychiatry. 2006, 45: 527-537. 10.1097/01.chi.0000205710.01690.d4.
Stathis SL, O'Callaghan M, Harvey J, Rogers Y: Head circumference in ELBW babies is associated with learning difficulties and cognition but not ADHD in the school-aged child. Developmental Medicine & Child Neurology. 1999, 41: 375-380. 10.1017/S0012162299000833.
Riegel K, Ohrt B, Wolke D, Österlund K: Die Entwicklung gefährdet geborener Kinder bis zum funften Lebensjahr. [The development of children born at risk until their fifth year of life.]. 1995, Stuttgart: Fernind Enke Verlag
Lano A: The Value of Neonatal Neurological Assessment in Predicting Neurodevelopmental Problems at Preschool Age. 2002, Helsinki: Faculty of Medicine, Department of Child Neurology, University of Helsinki
Heinonen K, Raikkonen K, Pesonen AK, Kajantie E, Andersson S, Eriksson JG, Niemela A, Vartia T, Peltola J, Lano A: Prenatal and postnatal growth and cognitive abilities at 56 months of age: a longitudinal study of infants born at term. Pediatrics. 2008, 121: e1325-1333. 10.1542/peds.2007-1172.
Dubowitz LM, Dubowitz V, Goldberg C: Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970, 77: 1-10. 10.1016/S0022-3476(70)80038-5.
Conners CK: Conners' Hyperactivity Index. 1989, Totonto: Multi-Health Systems Inc, 1990
Altfas JR: Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry. 2002, 2: 9-10.1186/1471-244X-2-9.
Modesto-Lowe V, Danforth JS, Brooks D: ADHD: does parenting style matter?. Clin Pediatr (Phila). 2008, 47: 865-872. 10.1177/0009922808319963.
Murray C, Johnston C: Parenting in mothers with and without attention-deficit/hyperactivity disorder. J Abnorm Psychol. 2006, 115: 52-61.
Counts CA, Nigg JT, Stawicki JA, Rappley MD, von Eye A: Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems. J Am Acad Child Adolesc Psychiatry. 2005, 44: 690-698. 10.1097/01.chi.0000162582.87710.66.
Rothman KJ: No adjustments are needed for multiple comparisons. Epidemiology. 1990, 1: 43-46. 10.1097/00001648-199001000-00010.
Perneger TV: What's wrong with Bonferroni adjustments. BMJ. 1998, 316: 1236-1238.
Hollo O, Rautava P, Korhonen T, Helenius H, Kero P, Sillanpaa M: Academic achievement of small-for-gestational-age children at age 10 years. Arch Pediatr Adolesc Med. 2002, 156: 179-187.
Ptacek R, Kuzelova H, Paclt I, Zukov I, Fischer S: ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys. Medical Science Monitor. 2009, 15: CR595-599.
Hack M, Breslau N, Weissman B, Aram D, Klein N, Borawski E: Effect of very low birth weight and subnormal head size on cognitive abilities at school age. The New England Journal of Medicine. 1991, 325: 231-237. 10.1056/NEJM199107253250403.
Bartholomeusz HH, Courchesne E, Karns CM: Relationship between head circumference and brain volume in healthy normal toddlers, children, and adults. Neuropediatrics. 2002, 33: 239-241. 10.1055/s-2002-36735.
Krain AL, Castellanos FX: Brain development and ADHD. Clin Psychol Rev. 2006, 26: 433-444. 10.1016/j.cpr.2006.01.005.
Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL: Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 2002, 288: 1740-1748. 10.1001/jama.288.14.1740.
Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, Clasen L, Evans A, Giedd J, Rapoport JL: Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007, 104: 19649-19654. 10.1073/pnas.0707741104.
Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL: Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999, 2: 861-863. 10.1038/13158.
Biederman J, Faraone SV, Monuteaux MC, Plunkett EA, Gifford J, Spencer T: Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics. 2003, 111: 1010-1016. 10.1542/peds.111.5.1010.
Curtin C, Bandini LG, Perrin EC, Tybor DJ, Must A: Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review. BMC Pediatrics. 2005, 5: 48-10.1186/1471-2431-5-48.
Cortese S, Angriman M, Maffeis C, Isnard P, Konofal E, Lecendreux M, Purper-Ouakil D, Vincenzi B, Bernardina BD, Mouren MC: Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Critical Reviews in Food Science and Nutrition. 2008, 48: 524-537. 10.1080/10408390701540124.
Gustafsson P, Thernlund G, Besjakov J, Karlsson MK, Ericsson I, Svedin CG: ADHD symptoms and maturity--a study in primary school children. Acta Paediatrica. 2008, 97: 233-238. 10.1111/j.1651-2227.2007.00608.x.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/11/84/prepub
We acknowledge Juha Peltola and Anja Niemelä for their contribution in data collection. This study was supported by grants from Academy of Finland, Helsinki University's Research Funds, European Science Foundation, Ministry of Education, Emil Aaltonen Foundation, Signe and Ane Gyllenberg's Foundation, Ahokas Foundation, Yrjö Jahnsson's Foundation, Finnish Foundation for Pediatric Reseach., Grant JUG 14 by the Federal Government of Germany Ministry of Science and Technology (BMBF).
The authors declare that they have no competing interests.
KH and KR made substantial contributions to analysis and interpretation of data and have been involved in drafting the manuscript and revising it critically for important intellectual content. A-KP, SA, EK, JGE have contributed to analysis and interpretation of data, and have been involved in revising manuscript critically for important intellectual content; DW has made substantial contributions to conception and design, and to interpretation of data, and has revised manuscript critically for important intellectual content. TV, AL have made substantial contributions acquisition of data and have been involved in revising manuscript critically for important intellectual content. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.